DOK1 and Burkitt lymphoma: Indeed several mechanisms of DOK1 inactivation have been characterized so far DOK1 expression was found to be silenced by hypermethylation of its promoter in a variety of human cancers, including, head and neck, lung, gastric and liver cancer as well as in Burkitt's lymphoma-derived cell lines [9], [10], [11].